Veristat has launched its Clinical Trial, Biostatistics and Programming operations in Taipei, Taiwan with the opening of a new office.

The expansion of operations into Taiwan is aimed at supporting growing client demand for clinical trial, biostatistics and programming excellence in the region.

Veristat CEO Patrick Flanagan said: “The growth of Veristat’s operations in Taiwan is a critical next step in supporting our clients looking to prepare their clinical trial data for marketing applications worldwide.

“We have strategically selected Taipei, Taiwan, as our entry into Asia because the location complements our core values and culture of partnership, respect, innovation, and agility.

“We are building a highly-experienced team of statistical programmers and clinical trial professionals in our new Taipei office to better serve our clients and their increasing requests for local and international regulatory submission support.”

The company plans to host the opening celebration of the new office on 02 September of this year.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Veristat Taipei operations director Philip Ho said: “Establishing a footprint in Taipei allows local Veristat programmers to support the fast-growing clinical development market in Taiwan. My team is growing to support submission programs for both local sponsors, as well as our North American sponsors.”

Based in the US, Veristat is a clinical research organization (CRO) and partners with pharmaceutical, biotechnology, and medical device firms to advance their therapies from clinical development stage to regulatory submission process.

The company has strategic experience in decision-making and biometrics expertise to collect, audit and report clinical trial data to various regulatory agencies.